메뉴 건너뛰기




Volumn 28, Issue 3, 2012, Pages 223-229

Complications of cirrhosis

Author keywords

ascites; cirrhosis; esophageal varices; hepatic encephalopathy; hepatorenal syndrome; liver biopsy; portal hypertension; variceal hemorrhage

Indexed keywords

ALBUMIN; BETA ADRENERGIC RECEPTOR BLOCKING AGENT; CYANOACRYLATE; ERYTHROMYCIN; LACTULOSE; ORNITHINE ASPARTATE; PENTOXIFYLLINE; PLACEBO; PROBIOTIC AGENT; PROPRANOLOL; RIFAXIMIN; TERLIPRESSIN;

EID: 84859925441     PISSN: 02671379     EISSN: 15317056     Source Type: Journal    
DOI: 10.1097/MOG.0b013e328351d003     Document Type: Review
Times cited : (43)

References (18)
  • 2
    • 78651253802 scopus 로고    scopus 로고
    • Liver related mortality in the US is underestimated
    • A169
    • Asrani S, Kamath P, Pedersen R, et al. Liver related mortality in the US is underestimated. Hepatology 2010; 52:408; A169.
    • (2010) Hepatology , vol.52 , pp. 408
    • Asrani, S.1    Kamath, P.2    Pedersen, R.3
  • 4
    • 77957173694 scopus 로고    scopus 로고
    • Complication rate of percutaneous liver biopsies among persons with advanced chronic liver disease in the HALT-C trial
    • Seeff LB, Everson GT, Morgan TR, et al. Complication rate of percutaneous liver biopsies among persons with advanced chronic liver disease in the HALT-C trial. Clin Gastroenterol Hepatol 2010; 8:877-883.
    • (2010) Clin Gastroenterol Hepatol , vol.8 , pp. 877-883
    • Seeff, L.B.1    Everson, G.T.2    Morgan, T.R.3
  • 5
    • 77950246404 scopus 로고    scopus 로고
    • Rifaximin treatment in hepatic encephalopathy
    • Bass NM, Mullen KD, Sanyal A, et al. Rifaximin treatment in hepatic encephalopathy. N Engl J Med 2010; 362:1071-1081.
    • (2010) N Engl J Med , vol.362 , pp. 1071-1081
    • Bass, N.M.1    Mullen, K.D.2    Sanyal, A.3
  • 6
    • 79960698297 scopus 로고    scopus 로고
    • A randomized controlled trial comparing lactulose, probiotics, and L-ornithine L-aspartate in treatment of minimal hepatic encephalopathy
    • Mittal VV, Sharma BC, Sharma P, Sarin SK. A randomized controlled trial comparing lactulose, probiotics, and L-ornithine L-aspartate in treatment of minimal hepatic encephalopathy. Eur J Gastroenterol Hepatol 2011; 23:725-732.
    • (2011) Eur J Gastroenterol Hepatol , vol.23 , pp. 725-732
    • Mittal, V.V.1    Sharma, B.C.2    Sharma, P.3    Sarin, S.K.4
  • 7
    • 79251535022 scopus 로고    scopus 로고
    • Rifaximin improves driving simulator performance in a randomized trial of patients with minimal hepatic encephalopathy
    • Bajaj JS, Heuman DM, Wade JB, et al. Rifaximin improves driving simulator performance in a randomized trial of patients with minimal hepatic encephalopathy. Gastroenterology 2011; 140:478-487; e1.
    • (2011) Gastroenterology , vol.140
    • Bajaj, J.S.1    Heuman, D.M.2    Wade, J.B.3
  • 8
    • 77955307851 scopus 로고    scopus 로고
    • Clinical efficacy of transjugular intrahepatic portosystemic shunt created with covered stents with different diameters: Results of a randomized controlled trial
    • Riggio O, Ridola L, Angeloni S, et al. Clinical efficacy of transjugular intrahepatic portosystemic shunt created with covered stents with different diameters: results of a randomized controlled trial. J Hepatol 2010; 53:267-272.
    • (2010) J Hepatol , vol.53 , pp. 267-272
    • Riggio, O.1    Ridola, L.2    Angeloni, S.3
  • 9
    • 77956632211 scopus 로고    scopus 로고
    • Deleterious effects of beta-blockers on survival in patients with cirrhosis and refractory ascites
    • Serste T, Melot C, Francoz C, et al. Deleterious effects of beta-blockers on survival in patients with cirrhosis and refractory ascites. Hepatology 2010; 52:1017-1022.
    • (2010) Hepatology , vol.52 , pp. 1017-1022
    • Serste, T.1    Melot, C.2    Francoz, C.3
  • 10
    • 80052943315 scopus 로고    scopus 로고
    • Beta-blockers cause paracentesisinduced circulatory dysfunction in patients with cirrhosis and refractory ascites: A cross-over study
    • Serste T, Francoz C, Durand F, et al. Beta-blockers cause paracentesisinduced circulatory dysfunction in patients with cirrhosis and refractory ascites: a cross-over study. J Hepatol 2011; 55:794-799.
    • (2011) J Hepatol , vol.55 , pp. 794-799
    • Serste, T.1    Francoz, C.2    Durand, F.3
  • 11
    • 79960450415 scopus 로고    scopus 로고
    • Predictors of response to terlipressin plus albumin in hepatorenal syndrome (HRS) type 1: Relationship of serum creatinine to hemodynamics
    • Boyer TD, Sanyal AJ, Garcia-Tsao G, et al. Predictors of response to terlipressin plus albumin in hepatorenal syndrome (HRS) type 1: relationship of serum creatinine to hemodynamics. J Hepatol 2011; 55:315-321.
    • (2011) J Hepatol , vol.55 , pp. 315-321
    • Boyer, T.D.1    Sanyal, A.J.2    Garcia-Tsao, G.3
  • 12
    • 79951942093 scopus 로고    scopus 로고
    • Prevention of hepatorenal syndrome in patients with cirrhosis and ascites: A pilot randomized control trial between pentoxifylline and placebo
    • Tyagi P, Sharma P, Sharma BC, et al. Prevention of hepatorenal syndrome in patients with cirrhosis and ascites: a pilot randomized control trial between pentoxifylline and placebo. Eur J Gastroenterol Hepatol 2011; 23:210-217.
    • (2011) Eur J Gastroenterol Hepatol , vol.23 , pp. 210-217
    • Tyagi, P.1    Sharma, P.2    Sharma, B.C.3
  • 13
    • 84856758917 scopus 로고    scopus 로고
    • Acute kidney injury and chronic kidney disease in hospitalized patients with cirrhosis
    • Warner NS, Cuthbert JA, Bhore R, Rockey DC. Acute kidney injury and chronic kidney disease in hospitalized patients with cirrhosis. J Investig Med 2011; 59:1244-1251.
    • (2011) J Investig Med , vol.59 , pp. 1244-1251
    • Warner, N.S.1    Cuthbert, J.A.2    Bhore, R.3    Rockey, D.C.4
  • 14
    • 34548120893 scopus 로고    scopus 로고
    • Diagnosis, prevention and treatment of hepatorenal syndrome in cirrhosis
    • DOI 10.1136/gut.2006.107789
    • Salerno F, Gerbes A, Gines P, et al. Diagnosis, prevention and treatment of hepatorenal syndrome in cirrhosis. Gut 2007; 56:1310-1318. (Pubitemid 47300435)
    • (2007) Gut , vol.56 , Issue.9 , pp. 1310-1318
    • Salerno, F.1    Gerbes, A.2    Gines, P.3    Wong, F.4    Arroyo, V.5
  • 15
    • 77649334176 scopus 로고    scopus 로고
    • Management of varices and variceal hemorrhage in cirrhosis
    • Garcia-Tsao G, Bosch J. Management of varices and variceal hemorrhage in cirrhosis. N Engl J Med 2010; 362:823-832.
    • (2010) N Engl J Med , vol.362 , pp. 823-832
    • Garcia-Tsao, G.1    Bosch, J.2
  • 16
    • 79955986650 scopus 로고    scopus 로고
    • Endoscopic variceal band ligation compared with propranolol for prophylaxis of first variceal bleeding
    • Drastich P, Lata J, Petrtyl J, et al. Endoscopic variceal band ligation compared with propranolol for prophylaxis of first variceal bleeding. Ann Hepatol 2011; 10:142-149.
    • (2011) Ann Hepatol , vol.10 , pp. 142-149
    • Drastich, P.1    Lata, J.2    Petrtyl, J.3
  • 17
    • 79956155925 scopus 로고    scopus 로고
    • Primary prophylaxis of gastric variceal bleeding comparing cyanoacrylate injection and beta-blockers: A randomized controlled trial
    • Mishra SR, Sharma BC, Kumar A, Sarin SK. Primary prophylaxis of gastric variceal bleeding comparing cyanoacrylate injection and beta-blockers: a randomized controlled trial. J Hepatol 2011; 54:1161-1167.
    • (2011) J Hepatol , vol.54 , pp. 1161-1167
    • Mishra, S.R.1    Sharma, B.C.2    Kumar, A.3    Sarin, S.K.4
  • 18
    • 79551682092 scopus 로고    scopus 로고
    • Effect of erythromycin before endoscopy in patients presenting with variceal bleeding: A prospective, randomized, double-blind, placebo-controlled trial
    • Altraif I, Handoo FA, Aljumah A, et al. Effect of erythromycin before endoscopy in patients presenting with variceal bleeding: a prospective, randomized, double-blind, placebo-controlled trial. Gastrointest Endosc 2011; 73:245-250.
    • (2011) Gastrointest Endosc , vol.73 , pp. 245-250
    • Altraif, I.1    Handoo, F.A.2    Aljumah, A.3


* 이 정보는 Elsevier사의 SCOPUS DB에서 KISTI가 분석하여 추출한 것입니다.